Many are searching for the right organization to donate to in this season of giving and as 2017 draws to a close. With so many nonprofits out there doing great work it may be difficult to know where to donate. This remains especially true for those who are passionate about the fight against cancer. Thankfully, trusted organizations like Consumer Reports make it a little easier to decide by putting together lists of charitable organizations that the public can also trust.
Consumer Reports has listed CRI as one of five top charities to give to in cancer. While the Cancer Research Institute community is familiar with our work and knows we are among the highest rated cancer charities, it's nice to be acknowledged by third parties we know and rely on. Our community of supporters are passionate and committed to the fight against cancer, so we do all that we can to ensure their dollars are used wisely and effectively. We are dedicated to keeping overhead costs low, so that the majority of donations go straight to our programs. We are proud to say that we have an A rating from CharityWatch, hold a 4-out-of-4-star rating from Charity Navigator, bear the GuideStar Gold Exchange Seal, and are a member of the Better Business Bureau’s Wise Giving Alliance.
To those who continue to give to CRI and all of those who will, we thank you for supporting the one cause to cure all cancers this holiday season!
Cindy Stowell Continues to Inspire
Read Previous Article
Immunotherapy Shines at ASH and ESMO IO Conferences
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
We spoke with Dr. Yvonne Chen to learn more about her work in chemical engineering to fight cancer and what she hopes to accomplish during the next five years as a CRI Lloyd J. Old STAR.
We round up the latest immunotherapy for pancreatic cancer news and research from the scientists, physicians, and patients changing the future of pancreatic cancer treatment.